On May 21 and 22, 2010, the McCombs School of Business faculty welcomed 1658 new alumni at commencement celebrations across campus - 773 BBA, 520 MBA, 315 MPA, 43 MSTC and 7 Ph.D. students. Congratulations to all of our graduates!
Business blogger and editor Renee Hopkins will be joining the McCombs School of Business on June 21, as the editor of Texas Enterprise, a new online publication geared to business and academic audiences.
John Sibley Butler, director of the IC2 Institute at The University of Texas at Austin, and the Kelleher Center for Entrepreneurship at McCombs School of Business, will welcome 32 Fulbright foreign students from June 1 to 4, for a seminar on translating scientific discovery into economic and social progress.
Former President Bill Clinton spoke at a sustainability conference in San Antonio last week. Other Big 12 and UT System schools were there, eager to hear his tips on making operations more eco-friendly. But guess whom he showed support for?
Economists in the Federal Reserve Bank of Philadelphia's "Survey of Professional Forecasters" have been predicting a slow and steady recovery over the next couple of years, which is unusual for an economy coming out of such a deep recession.
On April 29-30, The University of Texas at Austin hosted its first symposium on health care delivery, titled “Innovation in Health Care Delivery Systems: Maintaining Quality and Reducing Costs Through Management and Information Technology,” at the AT&T Executive Education and Conference Center.
Moot Corp, the University of Texas business plan competition, has a new name: Venture Labs Investment Competition. This year’s competition, which took place over the weekend, involved 40 teams from 12 countries and included categories from clean energy to biotechnology to information technology to consumer products.
BiologicsMD is the 27th Global Champion of the Global Moot Corp Competition, which was held May 7-8 at the AT&T Executive Education and Conference Center. This year’s Global Moot Corp Competition brought 40 teams from 12 countries to Austin. Biologics MD is developing OsteoFlor, a new prescription medicine for the treatment of osteoporosis.